Literature DB >> 21104968

Synthesis and analysis of the membrane proximal external region epitopes of HIV-1.

Sampat Ingale1, Johannes S Gach, Michael B Zwick, Philip E Dawson.   

Abstract

The membrane proximal external region (MPER) of gp41 abuts the viral membrane at the base of HIV-1 envelope glycoprotein spikes. The MPER is highly conserved and is rich in Trp and other lipophilic residues. The MPER is also required for the infection of host cells by HIV-1 and is the target of the broadly neutralizing antibodies, 4E10, 2F5, and Z13e1. These neutralizing antibodies are valuable tools for understanding relevant conformations of the MPER and for studying HIV-1 neutralization, but multiple approaches used to elicit MPER binding antibodies with similar neutralization properties have failed. Here we report our efforts to mimic the MPER using linear as well as constrained peptides. Unnatural amino acids were also introduced into the core epitope of 4E10 to probe requirements of antibody binding. Peptide analogs with C-terminal Api or Aib residues designed to be helical transmembrane (TM) domain surrogates exhibit enhanced binding to the 4E10 and Z13e1 antibodies. However, we find that placement of constrained amino acids at nonbinding sites within the core epitope significantly reduce binding. These results are relevant to an understanding of native MPER structure on HIV-1, and form a basis for a chemical synthesis approach to mimic MPER stricture and to construct an MPER-based vaccine.
Copyright © 2010 European Peptide Society and John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21104968     DOI: 10.1002/psc.1325

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  12 in total

1.  Rational design of membrane proximal external region lipopeptides containing chemical modifications for HIV-1 vaccination.

Authors:  Vincent J Venditto; Douglas S Watson; Michael Motion; David Montefiori; Francis C Szoka
Journal:  Clin Vaccine Immunol       Date:  2012-10-31

2.  Conformational properties of peptides corresponding to the ebolavirus GP2 membrane-proximal external region in the presence of micelle-forming surfactants and lipids.

Authors:  Lauren K Regula; Richard Harris; Fang Wang; Chelsea D Higgins; Jayne F Koellhoffer; Yue Zhao; Kartik Chandran; Jianmin Gao; Mark E Girvin; Jonathan R Lai
Journal:  Biochemistry       Date:  2013-05-07       Impact factor: 3.162

3.  Structure-based design of a protein immunogen that displays an HIV-1 gp41 neutralizing epitope.

Authors:  Robyn L Stanfield; Jean-Philippe Julien; Robert Pejchal; Johannes S Gach; Michael B Zwick; Ian A Wilson
Journal:  J Mol Biol       Date:  2011-10-15       Impact factor: 5.469

4.  Binding of anti-membrane-proximal gp41 monoclonal antibodies to CD4-liganded and -unliganded human immunodeficiency virus type 1 and simian immunodeficiency virus virions.

Authors:  Ramesh Rathinakumar; Moumita Dutta; Ping Zhu; Welkin E Johnson; Kenneth H Roux
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

5.  C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: effects of conjugation to cholesterol and side chain-side chain crosslinking.

Authors:  Chelsea D Higgins; Jayne F Koellhoffer; Kartik Chandran; Jonathan R Lai
Journal:  Bioorg Med Chem Lett       Date:  2013-08-02       Impact factor: 2.823

6.  Crystallographic Identification of Lipid as an Integral Component of the Epitope of HIV Broadly Neutralizing Antibody 4E10.

Authors:  Adriana Irimia; Anita Sarkar; Robyn L Stanfield; Ian A Wilson
Journal:  Immunity       Date:  2016-01-05       Impact factor: 31.745

7.  A High Throughput Protein Microarray Approach to Classify HIV Monoclonal Antibodies and Variant Antigens.

Authors:  Emmanuel Y Dotsey; Andrea Gorlani; Sampat Ingale; Chad J Achenbach; Donald N Forthal; Philip L Felgner; Johannes S Gach
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

8.  Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies.

Authors:  Gregory H Bird; Adriana Irimia; Gilad Ofek; Peter D Kwong; Ian A Wilson; Loren D Walensky
Journal:  Nat Struct Mol Biol       Date:  2014-11-24       Impact factor: 15.369

9.  HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional study.

Authors:  Johannes S Gach; Chad J Achenbach; Veronika Chromikova; Baiba Berzins; Nina Lambert; Gary Landucci; Donald N Forthal; Christine Katlama; Barbara H Jung; Robert L Murphy
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.752

10.  Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization.

Authors:  Arthur S Kim; Daniel P Leaman; Michael B Zwick
Journal:  PLoS Pathog       Date:  2014-07-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.